Brief: Vertex Pharmaceuticals Inc - Authorizes $4 Billion Stock Repurchase Program - SEC Filing
19/05/2025 21:48
Vertex Pharmaceuticals Inc VRTX.O: VERTEX PHARMACEUTICALS INC - AUTHORIZES $4 BILLION STOCK REPURCHASE PROGRAM - SEC FILING Source text: [ID:n0000875320-25-000199] Further company coverage: VRTX.O
Recent news on Vertex Pharmaceuticals Incorporated
See all newsBrief: Vertex Appoints Daniel Brennan To Its Board Of Directors
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Vertex rises after kidney disease drug shows promise in mid-stage study
Brief: Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR By -42.7% At Week 13 In AMKD With Modest Proteinuria